Covered recipient · General Payments record
PAUL J LAMA
Allopathic & Osteopathic Physicians Ophthalmology Glaucoma Specialist
General Payments · PY2018–2024
$67,309.02
- Reported across 255 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,381.00 | 4 |
| Food and Beverage | $1,167.17 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $12,237.31 | 10 |
| Alcon Laboratories Inc | $85.80 | 4 |
| ABBVIE INC. | $85.29 | 5 |
| Thea Pharma Inc. | $38.54 | 2 |
| Amgen Inc. | $32.92 | 2 |
| Oyster Point Pharma, Inc. | $20.35 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.82 | 1 |
| Bausch & Lomb Americas Inc. | $14.68 | 1 |
| BIOTISSUE HOLDINGS INC. | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.58 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104131790 | CMS |
| ABBVIE INC. | $17.02 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104131792 | CMS |
| ABBVIE INC. | $17.69 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104131794 | CMS |
| ABBVIE INC. | $16.01 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104131796 | CMS |
| ABBVIE INC. | $18.99 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104131798 | CMS |
| Alcon Vision LLC | $19.16 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110591553 | CMS |
| Alcon Vision LLC | $23.38 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110591557 | CMS |
| Alcon Vision LLC | $19.16 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110591555 | CMS |
| Alcon Vision LLC | $24.10 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110591559 | CMS |
| Amgen Inc. | $16.46 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115846941 | CMS |
| Amgen Inc. | $16.46 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115846949 | CMS |
| Bausch & Lomb Americas Inc. | $14.68 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140425618 | CMS |
| BIOTISSUE HOLDINGS INC. | $14.46 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148778917 | CMS |
| Glaukos Corporation | $185.54 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151994566 | CMS |
| Glaukos Corporation | $2,995.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151974324 | CMS |
| Glaukos Corporation | $188.80 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151980448 | CMS |
| Glaukos Corporation | $2,995.00 | 03/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151974322 | CMS |
| Glaukos Corporation | $36.26 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993753 | CMS |
| Glaukos Corporation | $105.95 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993755 | CMS |
| Glaukos Corporation | $2,396.00 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151973301 | CMS |
| Glaukos Corporation | $154.29 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993757 | CMS |
| Glaukos Corporation | $2,995.00 | 09/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151974326 | CMS |
| Glaukos Corporation | $185.47 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993759 | CMS |
| Oyster Point Pharma, Inc. | $20.35 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147416928 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.82 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152190252 | CMS |
| Thea Pharma Inc. | $19.59 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074542367 | CMS |
| Thea Pharma Inc. | $18.95 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074542369 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.